Friday, 4 December 2020

Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India



source https://www.pharmatutor.org/pharma-news/2020/zydus-receives-approval-from-dcgi-to-commence-phase-iii-clinical-trials-with-pegylated-interferon-alpha-2b-in-india

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...